Previous close | 28.50 |
Open | 28.50 |
Bid | 26.80 |
Ask | 30.30 |
Strike | 145.00 |
Expiry date | 2025-01-17 |
Day's range | 28.50 - 28.50 |
Contract range | N/A |
Volume | |
Open interest | 57 |
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2024 Earnings Call Transcript May 2, 2024 Alnylam Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.52272, expectations were $-0.75. ALNY isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for […]
Alnylam (ALNY) reports better-than-expected first-quarter 2024 results as both earnings and revenues beat estimates, primarily driven by strong Amvuttra sales.
Alnylam Pharmaceuticals ( NASDAQ:ALNY ) First Quarter 2024 Results Key Financial Results Revenue: US$494.3m (up 55...